Bicycle Therapeutics plc (BCYC) Net income 2017–2025
Bicycle Therapeutics plc (BCYC) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$219.0MFY2025 · since FY2017: -$16.3M → -$219.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$219.0M | -29.5% |
| FY2024 | -$169.0M | +6.4% |
| FY2023 | -$180.7M | -60.3% |
| FY2022 | -$112.7M | -68.7% |
| FY2021 | -$66.8M | -31.0% |
| FY2020 | -$51.0M | -66.7% |
| FY2019 | -$30.6M | -40.1% |
| FY2018 | -$21.8M | -34.4% |
| FY2017 | -$16.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BCYC financial trends
BCYC RevenueBCYC Net marginBCYC Gross profitBCYC Gross marginBCYC Operating incomeBCYC Operating marginBCYC Operating cash flowBCYC Free cash flowBCYC Capital expendituresBCYC Return on equityBCYC Stock buybacksBCYC Dividends paidBCYC Total assetsBCYC Total liabilitiesBCYC Shareholders’ equityBCYC overview →